Prospective study of a fluocinolone acetonide implant for chronic macular edema from central retinal vein occlusion: Thirty-six-month results

Ophthalmology

Volumn 119, Issue 1, 2012, Pages 132-137

  Jain, Nieraj ^a   Stinnett, Sandra S ^a   Jaffe, Glenn J ^a  

^a DUKE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CORTICOSTEROID; FLUOCINOLONE ACETONIDE; TISSUE PLASMINOGEN ACTIVATOR; TRIAMCINOLONE ACETONIDE; VASCULOTROPIN INHIBITOR;

ADULT; AGED; APHAKIA; ARTICLE; CASE STUDY; CATARACT EXTRACTION; CENTRAL FOVEAL THICKNESS; CENTRAL RETINA VEIN OCCLUSION; CLINICAL ARTICLE; CORTICOSTEROID THERAPY; DISEASE ASSOCIATION; DISEASE MARKER; DRUG DELIVERY SYSTEM; EARLY INTERVENTION; ENDOPHTHALMITIS; FEMALE; FLUORESCENCE ANGIOGRAPHY; FOLLOW UP; GLAUCOMA SURGERY; HUMAN; IMPLANTATION; INTERVENTION STUDY; INTRAOCULAR HYPERTENSION; INTRAOCULAR PRESSURE; LASER COAGULATION; LONG TERM CARE; MALE; OPTICAL COHERENCE TOMOGRAPHY; OUTCOME ASSESSMENT; PRACTICE GUIDELINE; PRIORITY JOURNAL; PROSPECTIVE STUDY; PSEUDOPHAKIA; RADIAL OPTIC NEUROTOMY; RETINA MACULA EDEMA; SCORING SYSTEM; TRABECULECTOMY; VISUAL ACUITY; VISUAL IMPAIRMENT; VITRECTOMY;

AGED; CATARACT EXTRACTION; CHRONIC DISEASE; DRUG IMPLANTS; FEMALE; FLUOCINOLONE ACETONIDE; FOLLOW-UP STUDIES; FOVEA CENTRALIS; GLUCOCORTICOIDS; HUMANS; INTRAOCULAR PRESSURE; MACULAR EDEMA; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; RETINAL VEIN OCCLUSION; TRABECULECTOMY; VISUAL ACUITY; VITREOUS BODY;

EID: 84855324053     PISSN: 01616420     EISSN: 15494713     Source Type: Journal    
DOI: 10.1016/j.ophtha.2011.06.019     Document Type: Article

References (18)

1. SCORE Study Research Group. A randomized trial comparing the efficacy and safety of intravitreal triamcinolone with observation to treat vision loss associated with macular edema secondary to central retinal vein occlusion: the Standard Care vs Corticosteroid for Retinal Vein Occlusion (SCORE) Study report 5. Arch Ophthalmol 2009;127:1101-14.
2. Brown DM, Campochiaro PA, Singh RP, et al. CRUISE Investigators. Ranibizumab for macular edema following central retinal vein occlusion: six-month primary end point results of a phase III study. Ophthalmology 2010;117:1124 -33.
3. Evaluation of grid pattern photocoagulation for macular edema in central vein occlusion: the Central Vein Occlusion Study Group M report. Ophthalmology 1995;102:1425-33.
4. Opremcak EM, Bruce RA, Lomeo MD, et al. Radial optic neurotomy for central retinal vein occlusion: a retrospective pilot study of 11 consecutive cases. Retina 2001;21:408 -15.
5. DeCroos FC, Shuler RK Jr, Stinnett S, Fekrat S. Pars plana vitrectomy, internal limiting membrane peeling, and panretinal endophotocoagulation for macular edema secondary to central retinal vein occlusion. Am J Ophthalmol 2009;147:627-33.
6. Haller JA, Bandello F, Belfort R Jr, et al. OZURDEX GENEVA Study Group. Randomized, sham-controlled trial of dexamethasone intravitreal implant in patients with macular edema due to retinal vein occlusion. Ophthalmology 2010;117:1134-46.
7. Fintak DR, Shah GK, Blinder KJ, et al. Incidence of endophthalmitis related to intravitreal injection of bevacizumab and ranibizumab. Retina 2008;28:1395-9.
8. Nelson ML, Tennant MT, Sivalingam A, et al. Infectious and presumed noninfectious endophthalmitis after intravitreal triamcinolone acetonide injection. Retina 2003;23:686 -91.
9. Jaffe GJ, Martin D, Callanan D, et al. Fluocinolone Acetonide Uveitis Study Group. Fluocinolone acetonide implant (Retisert) for noninfectious posterior uveitis: thirty-four-week results of a multicenter randomized clinical study. Ophthalmology 2006;113:1020 -7.
10. Jaffe GJ, Ben-Nun J, Guo H, et al. Fluocinolone acetonide sustained drug delivery device to treat severe uveitis. Ophthalmology 2000;107:2024 -33.
11. Jaffe GJ, Yang CH, Guo H, et al. Safety and pharmacokinetics of an intraocular fluocinolone acetonide sustained delivery device. Invest Ophthalmol Vis Sci 2000;41:3569-75.
12. Jaffe GJ, McCallum RM, Branchaud B, et al. Long-term follow-up results of a pilot trial of a fluocinolone acetonide implant to treat posterior uveitis. Ophthalmology 2005;112:1192-8.
13. Ramchandran RS, Fekrat S, Stinnett SS, Jaffe GJ. Fluocinolone acetonide sustained drug delivery device for chronic central retinal vein occlusion: 12-month results. Am J Ophthalmol 2008;146:285-91.
14. Callanan DG, Jaffe GJ, Martin DF, et al. Treatment of posterior uveitis with a fluocinolone acetonide implant: three-year clinical trial results. Arch Ophthalmol 2008;126:1191-201.
15. Dryden RM. Central retinal vein occlusions and chronic simple glaucoma. Arch Ophthalmol 1965;73:659-63.
16. Panek WC, Holland GN, Lee DA, Christensen RE. Glaucoma in patients with uveitis. Br J Ophthalmol 1990;74:223-7. (Pubitemid 20142781)
17. Goldstein DA, Godfrey DG, Hall A, et al. Intraocular pressure in patients with uveitis treated with fluocinolone acetonide implants. Arch Ophthalmol 2007;125:1478-85. (Pubitemid 350106679)
18. Campochiaro PA, Hafiz G, Shah SM, et al. Famous Study Group. Sustained ocular delivery of fluocinolone acetonide by an intravitreal insert. Ophthalmology 2010;117:1393-9.